Unified Business No.

54165507

Industry

Tobacco Manufacturing (1,186)

Listing

Listed (TPEx) (890) 6576

Founded

2013-02-08

Paid-in capital

NT$ 1,575,405,410

Phone

(02)77500188

Website

https://www.foreseepharma.com/

Exporter

Yes — registered with the Trade Administration

Annual revenue band

NT$100–500M

Ownership

Group subsidiary / corporate-held · Ying Shu Kai Man Chun Tao Shang ForeseePharmaceuticals,Inc.

Representative tenure

In office since 2013-02 (13 yrs)

Growth & profitability

Revenue 2026-09 YoY -1.1%, year-to-date -14.2%
Gross margin 68.3%, operating margin -92.3%, net margin 108.1% (2026-Q2 YTD)

Patents 1

• 2026 Method for preparing injectable sustained-release formulation

Similar companies 10

• TAIWANJ PHARMACEUTICALS, CO., LTD. Emerging stock (TPEx) NT$20–100M estimated
  Shared: Natural & engineering science R&D services, Western pharmaceutical retail
• TRIPARTITE THERAPEUTICS INC. Emerging stock (TPEx) NT$0.5–1B estimated
  Shared: Natural & engineering science R&D services
• CHO PHARMA INC. Emerging stock (TPEx) < NT$20M
  Shared: Natural & engineering science R&D services, Western pharmaceutical retail
• INPSYTECH, INC. Emerging stock (TPEx) NT$0.5–1B
  Shared: Natural & engineering science R&D services
• LIN BIOSCIENCE, INC. Emerging stock (TPEx) < NT$20M estimated
  Shared: Natural & engineering science R&D services
• Intelligene INC. Emerging stock (TPEx) NT$100–500M estimated
  Shared: Natural & engineering science R&D services
• ORIGINAL BIOMEDICALS CO., LTD. Emerging stock (TPEx) NT$100–500M estimated
  Shared: Natural & engineering science R&D services
• BRIM BIOTECHNOLOGY INC. Listed (TWSE) < NT$20M
  Shared: Natural & engineering science R&D services
• GOLDEN BIOTECHNOLOGY CORPORATION · New Taipei City Public company (unlisted) NT$20–100M
  Shared: Natural & engineering science R&D services
• LUMOSA THERAPEUTICS CO., LTD. Listed (TPEx) NT$20–100M
  Shared: Western pharmaceutical retail

Open in advanced filters →